FDA approves new treatment for patients with hypoplasminogenemia
Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type […]
» Read morenohealthproblemsnews.com
Home »
Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type […] In a new randomized trial that investigated the question of whether thrombolysis can be omitted for stroke patients undergoing endovascular […] STOCKHOLM (Reuters) – A previously healthy woman has died in Sweden about a week after being vaccinated with the AstraZeneca […] A novel drug that offers multilineage protection from chemotherapy-induced myelosuppression has been approved by the US Food and Drug Administration. […] Beware of the daily intake of Aspirin Doctors warned now to prevent that if healthy people take a daily Aspirin, […] Exposure to the main ingredient in smog may be linked to a type of bleeding stroke, according to new research. […] This blood can lead to vaginal bleeding during pregnancy. This article will look at the causes and risks of a […] Revamped drug that withstands extreme heat and has a 1,000-day shelf life could save almost 70,000 new mothers around the […]
FDA approves new treatment for patients with hypoplasminogenemia
Is There a Need for tPA Before Thrombectomy in Stroke?
One Swedish Person Dead After Getting AstraZeneca Vaccine Shot: Medical Products Agency
First Drug That Protects Against Chemo-Induced Myelosuppression
Study: Aspirin increases greatly the risk of internal bleeding
AHA: ozone pollution may be linked to a type of bleeding stroke
Subchorionic bleeding: Causes, symptoms, and risks
Revamped drug could save the 70,000 mothers who die from bleeding